Buy Cartalax Peptide

In short

Cartalax is sold here for laboratory research, in 1 size (20mg), starting at $85.00 a vial. Every batch arrives with a certificate naming the test that identified it, the test that measured its purity, and the date each was run. It is not an FDA-approved medicine. Research use only, and never for people or animals.

Cartalax specifications

Cartalax product specifications
Product name	Cartalax
Formula	C12H19N3O8
Physical form	Freeze-dried powder — a solid cake in a sealed vial
Appearance	White to off-white cake
Sizes on this page	20mg
Purity specification	≥99% by RP-HPLC. The number for the lot you receive is whatever its own certificate says.
Identity check	Mass spectrometry, read against the mass this compound should have
Net content	Weighed per lot and reported separately from purity
Lot documentation	At the laboratory — each certificate posts here the day it clears
Storage	Sealed, cold and out of the light
Ships from	Santa Ana, California — same business day on verified in-stock orders placed before 12 PM Pacific
Intended use	Laboratory research only. Not for human or animal use.

What is Cartalax, and what is it used for?

Supplier lists write it as Cartalax peptides or peptide Cartalax; every one of those is this record, and the lot certificate further down counts for more than the wording on a label.

Chemically: molecular formula C12H19N3O8, average mass 333.29 g/mol (PubChem CID 87815447). Those figures are what the identity test on a certificate is read against.

Class

Short synthetic peptide from the Khavinson "bioregulator" series.

Mechanism

Mechanism is not established in the conventional receptor sense. The originating group proposes that these peptides act epigenetically, entering cells and binding directly to specific DNA sequences to modulate transcription of tissue-relevant genes, with molecular docking used as the supporting method. That is a hypothesis about a mechanism, not a demonstrated pathway, and it has not been independently confirmed outside the groups that advanced it.

Where it appears in the literature

Appears in a preclinical literature of organotypic tissue culture, rodent models and gene-expression work, largely produced by the St Petersburg Institute of Bioregulation and Gerontology and collaborating Russian institutes. A substantial share is published in Russian, in journals with limited international circulation.

What is not established

No approved product outside Russia, no pharmacopoeial monograph, no independently replicated mechanism, and no controlled trial meeting United States or European standards. The volume of commercial writing about this series greatly exceeds what its cited sources report.

Cartalax for sale: 20mg vials, price per mg

Cartalax cost, and Cartalax price per mg by size

Cartalax is sold in 1 size here, 20mg, from $85.00 a vial. Cartalax cost starts at that figure for the smallest vial, and the Cartalax price per mg in the second column is the number to compare between sizes. The per-mg column is the honest comparison between sizes; the two tier columns show what ten and twenty vials of one size bill at, because the volume discount is per size and mixed sizes do not combine.

Cartalax sizes, cost per mg, and what each volume tier bills
Size	One vial	Per mg	10 vials −10%	20 vials −15%	Availability
Cartalax 20mg	$85.00	$4.25	$765.00$3.83/mg	$1,445.00$3.61/mg	Backordered — waitlist

Cartalax discounts: bulk pricing, Subscribe & Save, and codes

Three things move this price and nothing else does: how many vials of one size are on the order, whether that order repeats, and one code. The fourth column prices each route against the 20mg vial.

Cartalax: every buying option, what it takes off, and what the 20mg vial bills under it
Buying option	Takes off	When it applies	20mg at this option
One vial, one time	—	Any order	$85.00
10–19 vials of one size	10%	This order	$765.00$76.50 a vial
20 vials of one size	15%	This order	$1,445.00$72.25 a vial
Subscribe, every 1 month	6%	Shipment 2 onward	First $85.00, then $79.90
Subscribe, every 2 months	4%	Shipment 2 onward	First $85.00, then $81.60
Subscribe, every 3 months	2%	Shipment 2 onward	First $85.00, then $83.30
10 vials on a monthly subscription	10%, then 6% more	Shipment 2 onward	First $765.00, then $719.10
Sign-up code	10% of the order	One use, dead 24 hours after signup	$76.50 for one vial
Friday newsletter code	5% of the order	Live 24 hours, a new one each Friday	$80.75 for one vial
On-site offer code	5% of the order	Live 30 minutes from when it appears	$80.75 for one vial
Free standard shipping	The shipping charge	Orders over $200	3 vials

The first three stack; the codes do not. A volume discount comes off the line, a subscription cadence comes off that same line from shipment 2, and one code comes off what is left. One code per order, never two. A subscription runs a minimum of two shipments and can be cancelled once the second has shipped, and the first shipment always bills at today's eligible price with no cadence discount on it. The lowest this record ever bills is $3.40 per mg: twenty 20mg vials on a monthly subscription, from shipment 2 onward.

Every figure above is what you pay; nothing is added at checkout — dispatch and delivery work the same on every order.

Where to buy Cartalax: five checks before you order from anyone

Cartalax for sale, or Cartalax peptide for sale, means this page: one record, 1 size, a lot certificate for each. You can buy Cartalax online here with guest checkout; verified in-stock orders placed before 12 PM Pacific are dispatched the same day.

Run these on us too. A supplier who cannot pass them is asking you to take their word for it, and their word is the one thing a certificate exists to replace.

Check the certificate on the lab’s own site, not ours.
See whether it was written for the seller.
Match the lot number on the paper to the one on the vial.
Look for a method and a date next to every number.
Make sure identity was tested, not assumed.

Each of those is worked through, with what a failed check actually looks like, on verifying a certificate.

The Cartalax certificate: lot, purity, identity, and how to verify it

A certificate answers identity, purity and net content as three separate questions, each with the method that produced it and the date it was run — how to read one covers what each field does and does not cover. For Cartalax that means a mass spectrum landing on 333.29 g/mol for C12H19N3O8, the figure published against PubChem CID 87815447. The catalogued form is Ala-Glu-Asp (AED tripeptide), and the identity test resolves to that rather than to a related molecule with a similar name.

The certificate below belongs to one lot, and its number matches the one printed on the vial you receive. A real report for a different batch is still the wrong report.

Cartalax lot documentation by size
Size	Lot	Identity method	Purity	Test date
20mg	Pending verification	Pending verification	Pending verification	Pending verification

No lot documentation is published for Cartalax yet. Rather than display a placeholder certificate, this record shows the gap until each field has been verified against the lot in hand. The certificate index lists every lot the moment its report clears.

Solution arithmetic for the bench, with no administration guidance: the vial concentration calculator, preset to Cartalax.

Where the FDA stands on Cartalax

Not an FDA-approved drug product

The FDA has not approved this compound for anything, and nothing in this catalogue is a medicine. Where a compound stands legally depends on what it is, what form it is in, what it is being used for and which country you are in, and it changes over time, so the status shown here carries the date it was last checked.

Status verified 2026-08-25. Regulatory positions move; check the primary source before relying on any summary, including this one.

It is sold here as laboratory material under the research-use restriction that closes this page, which is not an approval, and not a statement that the compound is safe, effective or right for any purpose.

Cartalax research: what the published studies examine

Status: No FDA-approved application. This compound is sold as laboratory material. Where research on it has been published, it sits at the animal, cell or early-human stage, and this record does not summarise what it found. A supplier is not a neutral judge of evidence about its own catalogue.

Cartalax is the cartilage-associated member of the series and is indexed by PubMed under the tripeptide sequence Ala-Glu-Asp. The originating group proposes that these peptides act epigenetically, entering cells and binding directly to specific DNA sequences to modulate transcription of tissue-relevant genes, with molecular docking used as the supporting method. That is a hypothesis about a mechanism, not a demonstrated pathway, and it has not been independently confirmed outside the groups that advanced it.

The series was developed at the St Petersburg Institute of Bioregulation and Gerontology, and the design premise is tissue specificity: each short peptide is claimed to act on the organ its parent extract came from. That premise rests principally on explant-outgrowth assays from the same group.

Cartalax: reported findings and the model each came from
Reported observation	Model	Source
The originating review sets out the peptide theory of ageing and the design principle behind the series: dipeptides specific for thymus and tetrapeptides specific for heart, liver, brain cortex and pineal gland stimulate outgrowth of explants from their corresponding organs. It reports lifespan extension in rats, mice and fruit flies for the pineal preparations.	review of three decades of the originating group's own work	Khavinson, Peptides and Ageing, Neuroendocrinology Letters (2002)A 134-page supplement authored by the series originator reviewing his own institute's work. Foundational for the field and not an independent appraisal of it.
Synthetic peptides cardiogen, bronchogen, prostamax and pancragen were applied to organotypic explant cultures from heart, lung, prostate and pancreas of young (3-week) and aged (18-month) rats. At 0.05 ng/ml each stimulated explant outgrowth in its corresponding tissue relative to control across all groups — the tissue-specificity claim the series is built on.	organotypic explant culture, young and aged rat tissue	Zakutskii and colleagues, The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissue culture in young and old rats, Advances in Gerontology (2006)Published in Russian with an English abstract. Explant outgrowth in culture is a long way from a tissue effect in an animal.

Open questions. The indexed literature specific to Cartalax is very thin. Its cartilage association comes from the tissue-extract origin of the series rather than from published work in cartilage, and no study in the indexed record examines it in that tissue. Two limitations apply to every compound in this series and are worth stating plainly rather than once at the bottom of a catalogue.

First, provenance: the great majority of primary work comes from one institute and its collaborators, much of it published in Russian, and independent replication outside that network is scarce. That is a limit on how confidently the findings can be read, not an allegation about them. Second, the assays: explant outgrowth in organotypic culture and gene-expression shifts in cultured cells are the dominant endpoints, and neither establishes what a compound does in an intact animal, let alone a person.

The proposed epigenetic mechanism — short peptides entering the nucleus and binding DNA directly — is supported largely by molecular docking, which is a computational prediction rather than a measurement.

Each row above describes an observation in the stated model. None of it describes what Cartalax would do in a person or an animal outside that model, and none of it is a recommendation to use it for anything.

Questions about Cartalax

Where to buy Cartalax Peptide, and can I get it online?

Here, in 1 size, with guest checkout and shipping across the United States. All sizes are on the waitlist at the moment, and typically return within 2 to 3 business days. Each size is tied to its own lot record, and a published certificate can be verified at the issuing laboratory before you order.

How much does Cartalax Peptide cost?

$85.00 for the 20mg vial, and the table above shows cost per mg for each, which is the comparison that transfers between sizes.

What is the cheapest way to buy Cartalax Peptide?

Twenty vials of one size on a monthly subscription. Ten to nineteen vials of a single size take 10% off and twenty take 15%, and mixed sizes do not combine toward either. A subscription then takes a further 6% monthly, 4% every two months or 2% every three, never on the first shipment and always from shipment 2 onward. One discount code comes off whatever is left, one code per order. On the 20mg vial that is $85.00 once, $72.25 a vial at twenty, and $3.40 per mg on recurring shipments. Standard shipping is free over $200, which 3 of the 20mg vials reach.

What is Cartalax used for?

In the published research, Appears in a preclinical literature of organotypic tissue culture, rodent models and gene-expression work, largely produced by the St Petersburg Institute of Bioregulation and Gerontology and collaborating Russian institutes. No approved product outside Russia, no pharmacopoeial monograph, no independently replicated mechanism, and no controlled trial meeting United States or European standards. The volume of commercial writing about this series greatly exceeds what its cited sources report. This record sells it for laboratory work and says nothing about use in a person or an animal.

How does Cartalax work, and what does it do?

At the level the published literature describes it, mechanism is not established in the conventional receptor sense. No approved product outside Russia, no pharmacopoeial monograph, no independently replicated mechanism, and no controlled trial meeting United States or European standards. The volume of commercial writing about this series greatly exceeds what its cited sources report. This record sells it for laboratory work and says nothing about use in a person or an animal.

What does Cartalax do?

How do I verify the certificate of analysis is real?

Check it at the issuing laboratory rather than with the seller: the report carries a verification key or QR that resolves on the laboratory's own site, and one with the key stripped out is worthless however it looks. Reading a certificate covers the rest. For Cartalax the identity result should land on 333.29 g/mol for C12H19N3O8; a report whose mass is not that is either a different compound or a different form of it.

FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR PERSONAL, MEDICAL, DIAGNOSTIC, THERAPEUTIC, OR RECREATIONAL USE.